Sirtris Pharmaceuticals Inc.

News - Sirtris Pharmaceuticals Inc.

Sirtris Pharmaceuticals Presents at the American Diabetes Association's 68th Annual Scientific Sessions June 8

2008-06-04 09:00:39

Sirtris Pharmaceuticals, Inc.

Sirtris Receives Orphan Drug Designation From U.S. Food and Drug Administration for Resveratrol in Mitochondrial Disorder, MELAS Syndrome

2008-04-02 09:00:11

Sirtris Pharmaceuticals, Inc.

Sirtris Pharmaceuticals Scientific Advisor Shows SIRT1 Activation Improves Huntington's Disease In Preclinical Model

2008-03-28 09:00:10

Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging, announced that Sirtris Scientific Advisory Board Co-Chair Leonard P.

Sirtris Pharmaceuticals Presents at Future Leaders in the Biotechnology Industry Conference March 27

2008-03-24 09:00:11

Sirtris Pharmaceuticals, Inc.

Sirtris Announces First U.S. Patent Issued On Class of SIRT1 Activators; Patent Covers First NCE to Enter Human Clinical Trials

2008-03-19 09:00:08

Sirtris Pharmaceuticals, Inc.

More News (42 articles) »

News - Sirtris Pharmaceuticals Inc.

Breaking News

Streaming Video

Images and Photos

Space Exploration

Science and Research

Technology

My Health